CAMBRIDGE, Mass., Oct. 10, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) will be presenting at the 2017 BIO Investor Forum on Tuesday, October 17, 2017, at 10:45 a.m. PT (1:45 p.m. ET) in San Francisco, CA. A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.
Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Jaren Irene Madden, Senior Director,
Investor Relations and Corporate Communications
617-453-1336 or Jaren.Madden@infi.com